First Trust NYSE Arca Biotechnology Index Fund
113 hedge funds and large institutions have $317M invested in First Trust NYSE Arca Biotechnology Index Fund in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 28 increasing their positions, 35 reducing their positions, and 17 closing their positions.
445% more call options, than puts
Call options by funds: $2.07M | Put options by funds: $379K
24% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 17
12% more capital invested
Capital invested by funds: $282M → $317M (+$35.1M)
3% more funds holding
Funds holding: 110 → 113 (+3)
0.12% less ownership
Funds ownership: 35.01% → 34.89% (-0.12%)
20% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 35
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$6.27M |
| 2 |
Morgan Stanley
New York
|
+$5.21M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$5.13M |
| 4 |
OA
Oxbow Advisors
Austin,
Texas
|
+$2.54M |
| 5 |
Nomura Asset Management
Tokyo,
Japan
|
+$2.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NA
Navellier & Associates
Reno,
Nevada
|
-$6.12M |
| 2 |
HFM
Hartford Financial Management
Hartford,
Connecticut
|
-$5.36M |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$4.71M |
| 4 |
FEG
Financial Enhancement Group
Anderson,
Indiana
|
-$4.64M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$3.2M |
FBT Hedge Fund Activity: Q1 2017 in Review
113 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q1 2017, worth a combined $317M — up 12% from $282M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new FBT positions and 17 closed out — a net gain of 4 holders — while 28 added to existing stakes and 35 trimmed.
The largest buyer was UBS Group, adding an estimated $6.27M. The largest seller was Navellier & Associates, exiting entirely with an estimated $6.12M sold.
- 113 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q1 2017, up from 110 in Q4 2016.
- Funds reported $317M of First Trust NYSE Arca Biotechnology Index Fund stock for Q1 2017, up 12% quarter-over-quarter.
- 21 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q1 2017 and 17 closed out, a net change of +4 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q1 2017 was UBS Group, an estimated $6.27M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q1 2017 was Navellier & Associates, an estimated $6.12M sold.
Based on aggregated 13F filings for Q1 2017.